生技合约生产市场－全球产业规模、份额、趋势、机会和预测，按服务、类型、营运规模、治疗领域、地区和竞争格局划分，2020-2030年预测

2024年全球生技合约生产市场规模为221.5亿美元，预计2030年将以7.48%的复合年增长率成长至341.5亿美元。生技合约生产是指将药物研发和生产的专业服务外包给第三方机构，使生物製药公司能够专注于研发等核心竞争力。这些服务通常包括细胞株开发、製程优化、生产、製剂、填充和包装等。

主要市场驱动因素

全球生物技术合约生产市场受到生物製剂和先进疗法需求不断增长的显着影响。对包括单株抗体、细胞和基因疗法在内的复杂生物製品的日益关注，促使生物製药公司寻求合约研发生产机构的专业技术和先进的生产能力。

主要市场挑战

智慧财产权（IP）领域的复杂性对全球生物技术合约生产市场的成长构成了重大挑战。生物製药公司在与第三方机构合作时，必须谨慎处理专有资讯的保护和共享问题，这通常涉及复杂的协议和高昂的法律成本。

主要市场趋势

一个显着的趋势是全球供应链韧性的增强和分散式生产的推进。生物製药公司正积极寻求降低地缘政治不稳定和物流挑战带来的风险，从而增加对更在地化和多元化生产网络的投资。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球生物技术合约生产市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依服务项目分类（生产、配方及灌装、包装及贴标、其他服务）
  • 依类型（生物药物原料生产、生物药物製剂生产）
  • 依营运规模（商业营运、临床营运）划分
  • 依治疗领域划分（自体免疫疾病、心血管疾病、代谢性疾病、传染病、神经病学、其他治疗领域）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美生物技术合约製造市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲生物技术合约製造市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太生物技术合约生产市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物技术合约製造市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲生物技术合约製造市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球生技合约製造市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Lonza Group Ltd.
• Thermo Fisher Scientific, Inc.
• Wuxi Biologics Co., Ltd.
• Catalent, Inc.
• Samsung Biologics Co., Ltd.
• Boehringer Ingelheim International GmbH
• Fujifilm Holdings Corporation
• Abbvie Inc.
• Eurofins Scientific SE
• Genscript Biotech Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Biotechnology Contract Manufacturing Market, valued at USD 22.15 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 34.15 Billion by 2030. Biotechnology contract manufacturing involves the outsourcing of specialized services for drug development and manufacturing to third-party organizations, enabling biopharmaceutical companies to concentrate on core competencies such as research and development. These services typically encompass cell line development, process optimization, manufacturing, formulation, fill-finish operations, and packaging.

Key Market Drivers

The global biotechnology contract manufacturing market is significantly shaped by the escalating demand for biologics and advanced therapies. This growing focus on complex biological products, including monoclonal antibodies and cell and gene therapies, drives biopharmaceutical companies to seek specialized expertise and advanced manufacturing capabilities from contract development and manufacturing organizations.

Key Market Challenges

The intricate landscape of intellectual property (IP) rights presents a significant challenge to the growth of the Global Biotechnology Contract Manufacturing Market. Biopharmaceutical companies engaging third-party organizations must meticulously navigate the protection and sharing of proprietary information, which often involves complex agreements and substantial legal costs. This complexity introduces hesitancy and can delay outsourcing decisions for critical drug development and manufacturing projects, directly impacting market expansion.

Key Market Trends

A significant trend involves the strengthening of global supply chain resilience and the move towards distributed manufacturing. Biopharmaceutical companies are actively seeking to mitigate risks associated with geopolitical instabilities and logistical challenges, driving investments in more localized and diversified production networks. According to Cytiva's 2023 Global Biopharma Resilience Index, overall supply chain resilience improved slightly from 6.72 in 2021 to 6.84 in 2023, indicating ongoing industry efforts to fortify manufacturing capabilities.

Key Market Players

• Lonza Group Ltd.
• Thermo Fisher Scientific, Inc.
• Wuxi Biologics Co., Ltd.
• Catalent, Inc.
• Samsung Biologics Co., Ltd.
• Boehringer Ingelheim International GmbH
• Fujifilm Holdings Corporation
• Abbvie Inc.
• Eurofins Scientific SE
• Genscript Biotech Corporation

Report Scope:

In this report, the Global Biotechnology Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Contract Manufacturing Market, By Service:

• Manufacturing
• Formulation and Fill-Finish
• Packaging and Labeling
• Other services

Biotechnology Contract Manufacturing Market, By Type:

• Biologic Drug Substance Manufacturing
• Biologic Drug ProductManufacturing

Biotechnology Contract Manufacturing Market, By Scale of Operation:

• Commercial Operations
• Clinical Operations

Biotechnology Contract Manufacturing Market, By Therapeutic Area:

• Autoimmune Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Infectious Diseases
• Neurology
• Other Therapeutic Areas

Biotechnology Contract Manufacturing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biotechnology Contract Manufacturing Market.

Available Customizations:

Global Biotechnology Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Contract Manufacturing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Manufacturing, Formulation and Fill-Finish, Packaging and Labeling, Other services)
  • 5.2.2. By Type (Biologic Drug Substance Manufacturing, Biologic Drug ProductManufacturing)
  • 5.2.3. By Scale of Operation (Commercial Operations, Clinical Operations)
  • 5.2.4. By Therapeutic Area (Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Other Therapeutic Areas)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Biotechnology Contract Manufacturing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Type
  • 6.2.3. By Scale of Operation
  • 6.2.4. By Therapeutic Area
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biotechnology Contract Manufacturing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Scale of Operation
      • 6.3.1.2.4. By Therapeutic Area
  • 6.3.2. Canada Biotechnology Contract Manufacturing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Scale of Operation
      • 6.3.2.2.4. By Therapeutic Area
  • 6.3.3. Mexico Biotechnology Contract Manufacturing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Scale of Operation
      • 6.3.3.2.4. By Therapeutic Area

7. Europe Biotechnology Contract Manufacturing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Type
  • 7.2.3. By Scale of Operation
  • 7.2.4. By Therapeutic Area
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biotechnology Contract Manufacturing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Scale of Operation
      • 7.3.1.2.4. By Therapeutic Area
  • 7.3.2. France Biotechnology Contract Manufacturing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Scale of Operation
      • 7.3.2.2.4. By Therapeutic Area
  • 7.3.3. United Kingdom Biotechnology Contract Manufacturing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Scale of Operation
      • 7.3.3.2.4. By Therapeutic Area
  • 7.3.4. Italy Biotechnology Contract Manufacturing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Scale of Operation
      • 7.3.4.2.4. By Therapeutic Area
  • 7.3.5. Spain Biotechnology Contract Manufacturing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Scale of Operation
      • 7.3.5.2.4. By Therapeutic Area

8. Asia Pacific Biotechnology Contract Manufacturing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Type
  • 8.2.3. By Scale of Operation
  • 8.2.4. By Therapeutic Area
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biotechnology Contract Manufacturing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Scale of Operation
      • 8.3.1.2.4. By Therapeutic Area
  • 8.3.2. India Biotechnology Contract Manufacturing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Scale of Operation
      • 8.3.2.2.4. By Therapeutic Area
  • 8.3.3. Japan Biotechnology Contract Manufacturing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Scale of Operation
      • 8.3.3.2.4. By Therapeutic Area
  • 8.3.4. South Korea Biotechnology Contract Manufacturing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Scale of Operation
      • 8.3.4.2.4. By Therapeutic Area
  • 8.3.5. Australia Biotechnology Contract Manufacturing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Scale of Operation
      • 8.3.5.2.4. By Therapeutic Area

9. Middle East & Africa Biotechnology Contract Manufacturing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Type
  • 9.2.3. By Scale of Operation
  • 9.2.4. By Therapeutic Area
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biotechnology Contract Manufacturing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Scale of Operation
      • 9.3.1.2.4. By Therapeutic Area
  • 9.3.2. UAE Biotechnology Contract Manufacturing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Scale of Operation
      • 9.3.2.2.4. By Therapeutic Area
  • 9.3.3. South Africa Biotechnology Contract Manufacturing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Scale of Operation
      • 9.3.3.2.4. By Therapeutic Area

10. South America Biotechnology Contract Manufacturing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Type
  • 10.2.3. By Scale of Operation
  • 10.2.4. By Therapeutic Area
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biotechnology Contract Manufacturing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Scale of Operation
      • 10.3.1.2.4. By Therapeutic Area
  • 10.3.2. Colombia Biotechnology Contract Manufacturing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Scale of Operation
      • 10.3.2.2.4. By Therapeutic Area
  • 10.3.3. Argentina Biotechnology Contract Manufacturing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Scale of Operation
      • 10.3.3.2.4. By Therapeutic Area

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biotechnology Contract Manufacturing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Lonza Group Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. Wuxi Biologics Co., Ltd.
• 15.4. Catalent, Inc.
• 15.5. Samsung Biologics Co., Ltd.
• 15.6. Boehringer Ingelheim International GmbH
• 15.7. Fujifilm Holdings Corporation
• 15.8. Abbvie Inc.
• 15.9. Eurofins Scientific SE
• 15.10. Genscript Biotech Corporation

16. Strategic Recommendations

17. About Us & Disclaimer